We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
-1.48%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$475M
AUM Growth
-$34.1M
(-6.7%)
Cap. Flow
-$11.9M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
32.02%
Holding
95
New
18
Increased
29
Reduced
25
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Grocery Outlet
GO
|
+$8.02M |
| 2 |
Q2 Holdings
QTWO
|
+$6.19M |
| 3 |
Repligen
RGEN
|
+$6.12M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$6.02M |
| 5 |
Netflix
NFLX
|
+$5.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sarepta Therapeutics
SRPT
|
+$14M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$9.31M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
+$7.05M |
| 4 |
Okta
OKTA
|
+$6.25M |
| 5 |
Marriott Vacations Worldwide
VAC
|
+$5.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.9% |
| 2 | Technology | 17.5% |
| 3 | Communication Services | 13.07% |
| 4 | Consumer Discretionary | 11.14% |
| 5 | Materials | 4.56% |
Similar funds
AGA
ATS
RIM
ACM
CAM
LSA
GWA
Atika Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Atika Capital Management held 95 positions worth $475M, down 6.7% from $509M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Atika Capital Management's Q3 2019 filing shows 18 new, 29 increased, 25 reduced and 22 closed positions. Its largest new stake was Grocery Outlet: 211,500 shares worth $7.33M. The largest sale was Sarepta Therapeutics, an estimated $14M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.
- Atika Capital Management's largest Q3 2019 buy was Grocery Outlet: 211,500 shares worth $7.33M.
- Atika Capital Management added most to Netflix in Q3 2019, an estimated $5.48M increase.
- Atika Capital Management's biggest Q3 2019 reduction was Okta, cutting an estimated $6.25M.
- Atika Capital Management fully exited Sarepta Therapeutics in Q3 2019, selling an estimated $14M.
- Atika Capital Management's ten largest holdings make up 32% of its $475M portfolio in Q3 2019.
- Atika Capital Management opened 18 new positions and closed 22 in Q3 2019.
- Atika Capital Management's portfolio value fell 6.7% quarter-over-quarter to $475M.
Based on Atika Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.